Marc Dall'Era, M.D.

Marc A. Dall'Era, M.D.

Specialties

Cancer

Urologic Oncology

Urology

Department

Urology

Title

  • Associate Professor and Vice Chair of Urology
To see if Marc A. Dall'Era is accepting new patients, or for assistance finding a UC Davis doctor, please call 800-2-UCDAVIS (800-282-3284).

Lawrence J. Ellison Ambulatory Care Center

4860 Y St., Suite 2200
Sacramento, CA 95817
Driving Directions

Primary Phone:
916-734-2222

UC Davis Comprehensive Cancer Center

2279 45th Street
Sacramento, CA 95817
Driving Directions

Primary Phone:
800-362-5566
916-734-5959

4501 X St.
Sacramento, CA 95817
Driving Directions

Primary Phone:
800-362-5566

Additional Phone Numbers

Physician Referrals: 800-362-5566

Clinical Interests

I specialize in the management of malignant diseases of the kidney, bladder and prostate. My practice includes open, robotic and minimally invasive surgical approaches to urologic disease. My research interests include active surveillance and biomarker discovery for prostate cancer and translational research for urothelial diagnosis and management.

Division

Urology

Center/Program Affiliation

Robotic Surgery Program
UC Davis Comprehensive Cancer Center

Education

M.D., UC Davis, Davis, California, 2000

B.S., UC Davis, Davis, California, 1995

Residency

University of Washington, Seattle, WA, 2006

Fellowships

University of California, San Francisco, San Francisco, CA, 2008

Professional Memberships

American Medical Association

American Urologic Association

Society of Urologic Oncology

Select Recent Publications

Kim SI, Dall'era MA, Evans CP. Economic analysis of active surveillance for localized prostate cancer. Curr Opin Urol. 2012 May;22(3):247-53.

Dall'Era MA, Cowan JE, Simko J, Shinohara K, Davies B, Konety BR, Meng MV, Perez N, Greene K, Carroll PR. Surgical management after active surveillance for low-risk prostate cancer: pathological outcomes compared with men undergoing immediate treatment. BJU Int. 2011 Apr;107(8):1232-7.

Keegan KA, Dall'era MA, Durbin-Johnson B, Evans CP. Active surveillance for prostate cancer compared with immediate treatment: An economic analysis. Cancer. 2011 Dec 16. doi: 10.1002/cncr.26688. [Epub ahead of print]

Wu JN, Dall'Era MA. Active surveillance for localized prostate cancer--current practices and recommendations. ScientificWorldJournal. 2010 Dec 14;10:2352-61.

Marc A. Dall'Era and Peter R. Carroll. Outcomes and Follow-up Strategies for Patients on Active Surveillance: Current Opinion in Urology, Vol.19, Issue 3 pages 258-62. 2009.

Marc A. Dall'Era, Nap Hosang, Badrinath Konety, Janet E. Cowan and Peter R. Carroll. Sociodemographic Predictors of Prostate Cancer Risk Category at Diagnosis: Unique Patterns of Significant and Insignificant Disease. The Journal of Urology, Vol. 181, issue 4 pages 1622-1627. 2009.

Simon L. Conti, Marc Dall'Era, Vincent Fradet, Janet E. Cowan, Jeffery Simko, and Peter R. CArroll. Pathological Outcomes of Candidates for Active Surveillance of Prostate Cancer. The Journal of Urology, Vol. 181, pages 1628-1634. 2009.

Benjamin J. Davies, Marc C. Smaldone, Natalia Sadetsky, Marc Dall'Era and Peter R. Carroll. The Impact of Obesity on Overall and Cancer Specific Survival in Men with Prostate Cancer. The Journal of Urology, Vol. 182, issue 1, Pages 112-7. 2009.

Breyer BN, Greene KL, Dall’Era MA, Davies BJ, Kane CJ. Pelvic lymphadenectomy in prostate cancer. Prostate Cancer Prostatic Diseases, Vol. 11, issue 4. 2008

Dall'Era MA, Konety BR, Cowan JE, Shinohara K, Stauf F, Cooperberg MR, Meng MV, Kane CT, Perez N, Master V, Carroll PR. Active surveillance for the management of prostate cancer in a contemporary cohort. Cancer, Vol. 112 issue 12, pages 2664-70. 2008.

Dall’Era MA and Kane CJ. Watchful waiting versus active surveillance: Appropriate patient selection. Current Urology Reports. 9:211-216, 2008.

Walsh TJ, Dall'Era MA, Croughan MS, Carroll PR, Turek PJ. Prepubertal orchiopexy for cryptorchidism may be associated with lower risk of testicular cancer. J Urol. 178:1440-46, 2007